BeStock  
Stocks › Biotechnology › MRVI

Maravai LifeSciences MRVI

US equityMarket cap rank #3127Biotechnology
$6.98 −$0.21 (-2.92%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $6.98 0.00%
Open$7.06
Prev close$7.19
Day range$6.91 – $7.17
Volume1.79M
Market cap$1.04B
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±15.8%last 16 reports
Closed higher7 of 1644% of the time
Best reaction+63.6%
Worst reaction-35.3%

Stock move on the day after each report

+63.6%2023/Q4+11.2%2024/Q1-6.9%2024/Q2-35.3%2024/Q3-5.8%2024/Q4-2.8%2025/Q1+30.6%2025/Q2-0.7%2025/Q3+9.2%2025/Q4+23.1%2026/Q1-0.3%2026/Q2-9.6%2026/Q3
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q34 Nov 2026After Market±26.4%-9.59%Within range
2026/Q26 Aug 2026After Market±27.4%-0.32%Within range
2026/Q17 May 2026After Market–+23.10%–
2025/Q425 Feb 2026After Market±25.7%+9.20%Within range
2025/Q36 Nov 2025After Market–-0.69%–
2025/Q211 Aug 2025After Market±24.5%+30.58%Bigger than priced
2025/Q112 May 2025After Market±25.5%-2.83%Within range
2024/Q418 Mar 2025After Market±19.4%-5.81%Within range
2024/Q37 Nov 2024After Market±31.2%-35.27%Bigger than priced
2024/Q27 Aug 2024After Market±13.9%-6.87%Within range
2024/Q18 May 2024After Market±25.4%+11.16%Within range
2023/Q422 Feb 2024After Market±23.9%+63.60%Bigger than priced
2023/Q37 Nov 2023After Market±20.3%-31.69%Bigger than priced
2023/Q27 Aug 2023After Market±30.5%+0.73%Within range
2023/Q18 May 2023After Market±28.0%-13.02%Within range
2022/Q422 Feb 2023After Market±17.7%+8.17%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2026/Q3

By business line

  • TriLink$28.35M 61.8%
  • Cygnus$17.50M 38.2%

Latest reported quarter: Q3, ended Sep 2026

Revenue$45.85M+10.1% YoY
Operating profit-$17.70M+47.4% YoY
Net profit-$24.00M+46.7% YoY
Diluted EPS-$0.09+50.0% YoY
Free cash flow$4.49M+124.9% YoY
Operating cash flow$5.02M

Revenue, last 8 quarters

$56.6MDec '24$46.9MMar '25$47.4MJun '25$41.6MSep '25$49.9MDec '25$65.8MMar '26$51.4MJun '26$45.9MSep '26

Net profit, last 8 quarters

$-46.1MDec '24$-52.9MMar '25$-69.8MJun '25$-45.1MSep '25$-63.0MDec '25$-6.4MMar '26$-21.6MJun '26$-24.0MSep '26

Profitability & balance sheet

Gross margin39.1%
Operating margin-25.6%
Net margin-30.8%
Return on equity-29.8%
Return on assets-9.1%
Return on invested capital-10.3%
Current ratio4.66
Liabilities / assets43.3%
Cash & investments$73.02M
Total debt$176.48M
Net cash (debt)-$103.45M

Discussion

No comments yet — be the first to weigh in on MRVI.

Sign in to join the discussion.

Scroll to Top